PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Medical Intensive Care Unit, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, People\'s Republic of China.\', \'Department of Critical Care Medicine, Xuanwu Hospital, Capital Medical University, Beijing, People\'s Republic of China.\', \'Intensive Care Unit, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, People\'s Republic of China.\', \'Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, People\'s Republic of China.\', \'Intensive Care Unit, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, People\'s Republic of China.\', \'Department of Critical Care Medicine, Zhongda Hospital, Southeast University, Nanjing, Jiangsu, People\'s Republic of China.\', \'Intensive Care Unit, Shijiazhuang People\'s Hospital, Shijiangzhuang, Hebei, People\'s Republic of China.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1128/AAC.02045-21
?:hasPublicationType
?:journal
  • Antimicrobial agents and chemotherapy
is ?:pmid of
?:pmid
?:pmid
  • 35191746
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.291
?:rankingScore_hIndex
  • 226
?:title
  • Efficacy and Safety of SARS-CoV-2 Neutralizing Antibody JS016 in Hospitalized Chinese Patients with COVID-19: a Phase 2/3, Multicenter, Randomized, Open-Label, Controlled Trial.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35191746>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35191746>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all